Illuminare Biotechnologies develops Illuminare-1, a small molecule designed for real-time intraoperative nerve visualization to minimize the risk of nerve damage during surgical procedures. Currently in final stages of a first-in-human trial, this technology aims to enhance surgical outcomes by improving nerve illumination during radical prostatectomy.
Funding
Funding not disclosed
Founders
Product
Problem
Surgeons face challenges in clearly visualizing nerves during procedures, increasing the risk of unintended nerve damage and potentially leading to post-operative complications. Current methods for nerve identification can be imprecise, especially in complex surgical fields. This lack of clear visualization can prolong surgery times and negatively impact patient outcomes.
Solution
Illuminare Biotechnologies is developing Illuminare-1, a small molecule designed to enhance real-time intraoperative nerve visualization. This technology aims to improve surgical precision by providing surgeons with a clearer view of nerves during procedures. Illuminare-1 has a rapid onset of action and provides sustained nerve illumination. By improving nerve visualization, Illuminare-1 seeks to minimize the risk of nerve damage, reduce surgical times, and improve patient outcomes.
Target Audience
The primary target audience includes surgeons across various specialties who require enhanced nerve visualization during surgical procedures to minimize nerve damage.
Features
- Small molecule with rapid onset of action for immediate nerve illumination
- Sustained duration of nerve illumination during surgical procedures
- Designed for real-time intraoperative use
- Aims to improve nerve visualization during radical prostatectomy